| Quinolone &fluoroquinolone | Folate biosythesis inhibitor | Phenicol | Tetracyline | Aminoglycosides | Beta-Lactamase Inhibitor | |||||||||||||
N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | ||
Gender | Male | 33 (49.25) | 0.84 | 0.54 | 122 (53.28) | 1.07 | 0.73 | 59 (57.28) | 1.3 | 0.26 | 56 (48.28) | 0.77 | 0.26 | 134 (19.81) | 0.65 | 0.07 | 69 (51.11) | 0.91 | 0.66 |
Female | 34 (50.75) | R | - | 107 (46.72) | R | - | 44 (42.72) | R | - | 60 (51.70) | R | - | 135 (50.19) | R | - | 66 (48.89) | R | - | |
Residence | MN | 26 (38.81) | 1.67 | 0.07 | 86 (37.50) | - | - | 40 (38.83) | 1.81 | 0.02 | 54 (46.55) | 3.14 | 0.00 | 97 (36.06) | 4.35 | 0.00 | 61 (45.19) | 3.2 | 0.00 |
MR | 9 (13.43) | R | - | 44 (19.21) | - | - | 19 (18.45) | R | - | 13 (11.21) | R | - | 52 (19.33) | R | - | 21 (15.56) | R | - | |
VU | 32 (47.76) | - | - | 99 (43.23) | - | - | 44 (42.72) | - | - | 49 (42.24) | - | - | 120 (44.61) | - | - | 53 (39.20) | - | - | |
Age category | 0 - 50 | 38 (56.72) | 0.78 | 0.46 | 131 (57.21) | 0.62 | 0.09 | 64 (62.14) | 0.95 | 0.84 | 66 (56.90) | 0.98 | 0.97 | 156 (57.99) | 1.19 | 0.55 | 73 (54.07) | 0.925 | 0.773 |
51 - 100 | 18 (26.87) | R | - | 60 (26.20) | R | - | 26 (25.24) | R | - | 26 (22.41) | R | - | 58 (21.56) | R | - | 30 (22.22) | R | - | |
101 - 150 | 7 (10.45) | 0.51 | 0.20 | 34 (14.85) | 0.59 | 0.15 | 10 (9.71) | 0.47 | 0.08 | 19 (16.38) | 1.11 | 0.77 | 46 (17.10) | 1.87 | 0.13 | 27 (20.00) | 1.62 | 0.17 | |
151 - 200 | 4 (5.95) | 2.9 | 0.14 | 4 (1.75) | 0.32 | 0.11 | 3 (2.91) | 1.12 | 0.88 | 5 (4.31) | 2.79 | 0.15 | 9 (3.35) | - | - | 5 (3.70) | 2.25 | 0.25 | |
Symptoms | D | 33 (49.25) | 1.67 | 0.07 | 123 (53.71) | 0.97 | 0.89 | 53 (51.5) | 0.86 | 0.54 | 70 (60.34) | 1.46 | 0.09 | 167 (62.08) | 3.6 | 0.00 | 82 (60.74) | 1.54 | 0.05 |
ND | 34 (50.75) | R | - | 106 (46.29) | R | - | 50 (48.5) | R | - | 46 (39.66) | R | - | 102 (37.92) | R | - | 53 (39.26) | R | - |